Biohaven's Stock Drops After $150M Offering
Update: 2025-11-11
Description
Biohaven Limiteds stock drops 7% after announcing $150M public offering. The biopharmaceutical company plans to use funds for general corporate purposes, with J.P. Morgan and Goldman Sachs as book-running managers. Share dilution may impact existing stockholders.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
